MedPath

The Perioperative Value of Platelet Counts in Predicting Outcome After Liver Transplantation

Conditions
Death
Complication
Interventions
Procedure: Liver transplantation
Registration Number
NCT01711957
Lead Sponsor
University of Zurich
Brief Summary

Recent experimental and clinical studies have shown that platelets play a critical role in liver ischemia and regeneration. Thrombocytopenia, a frequent and potentially serious condition in liver transplantation (LT) recipients, was shown to be associated with postoperative morbidity and mortality after partial hepatectomy.

The investigators aim at evaluating whether postoperative low platelet counts are indicators of short- and long-term outcomes after liver transplantation.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
250
Inclusion Criteria
  • Age >18 years old
  • End stage liver disease
  • Cadaveric-donor liver transplantation
Read More
Exclusion Criteria
  • Age <18 years old
  • Pregnancy
  • Living-related liver transplantation
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Liver disease and liver transplantationLiver transplantationPatient with end stage liver disease and/or primary liver tumor undergoing liver transplantation
Primary Outcome Measures
NameTimeMethod
Severe complication after liver transplantation90 days

The severity of complications will be graded according to the Clavien-Dindo classification by outcome. Grade III to V complications will be considered as severe.

Secondary Outcome Measures
NameTimeMethod
Delayed graft function7 days after liver transplantation

Defined as the presence of at least one of the following parameter at 7 days after LT: serum bilirubin \> 10 mg/dL and International Normalized Ratio (INR) \>1.6 or Alanine aminotransferase serum level (ALT) \>2000UI/L

Primary graft non-functionfirst postoperative week

Defined as death or retransplantation within the first postoperative week after exclusion of technical, immunological, and infectious causes

Trial Locations

Locations (1)

University Hospital Zurich, Department of Visceral Surgery and Transplantation

🇨🇭

Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath